{
  "publisher": "gsk",
  "publicationYear": null,
  "description": null,
  "idForGivenType": "http://www.gsk-clinicalstudyregister.com/study/115-120?last_updated_from=2001-01-01&last_updated_to=2016-02-08",
  "id": "50|opentrials__::4f76540ffba3de631466cdef1c7a67a4",
  "titles": [
    "A Comparative Trial of a Combination of Atovaquone and Proguanil versus Chloroquine or Fansidar in the Treatment of Acute P. falciparum Malaria in Adults in Zambia"
  ],
  "resourceTypeValue": "0037",
  "formats": null,
  "referenceType": "url",
  "creatorNames": null,
  "alternateIdentifiers": {
    "gsk": "115-120"
  }
}
{
  "publisher": "ictrp",
  "publicationYear": null,
  "description": null,
  "idForGivenType": "https://www.clinicaltrials.gov/ct2/show/NCT00299546?lup_e=02%2F04%2F2016&lup_s=01%2F01%2F2001&rank=180982&resultsxml=true",
  "id": "50|opentrials__::bf43a83def68f37482ec2c9c61aeefc1",
  "titles": [
    "A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, a Fully Human Anti-TNFa Monoclonal Antibody, Administered Subcutaneously in Subjects With Active Rheumatoid Arthritis and Previously Treated With Biologic Anti- TNFa Agent(s)",
    "A Study of the Safety and Efficacy of Golimumab (CNTO 148) in Subjects With Active Rheumatoid Arthritis Previously Treated With Biologic Anti-TNFa Agent(s)"
  ],
  "resourceTypeValue": "0037",
  "formats": null,
  "referenceType": "url",
  "creatorNames": null,
  "alternateIdentifiers": {
    "ictrp": "NCT00299546"
  }
}
{
  "publisher": "[s.n.]",
  "publicationYear": "1927",
  "description": null,
  "idForGivenType": "10.5169\/seals-259119",
  "id": "oai:oai.datacite.org:1390724",
  "titles": [
    "Autour de la Soci\u00e9t\u00e9 des Nations"
  ],
  "resourceTypeValue": null,
  "formats": [
    "text\/html",
    "application\/pdf"
  ],
  "referenceType": "doi",
  "creatorNames": [
    "[s.n.]"
  ],
  "alternateIdentifiers": null
}